Ferroglobe PLC (GSM) (Q3 2026) Earnings Call Highlights: Negative EBITDA, $100

Ferroglobe PLC (GSM) reported negative adjusted EBITDA of -$2M in Q3 2026, down from $30M in Q2, due to high energy costs and lower shipments. The company plans to close five plants and reduce workforce by 20%, incurring $40-60M in costs. Q4 is expected to remain challenging. The CEO discussed potential plant restarts in Venezuela and the U.S., and the company's critical materials expansion, including discussions with the U.S. government.

Original reporting
Published Nov 6, 2026, 5:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 5:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ferroglobe PLC (GSM) (Q3 2026) Earnings Call Highlights: Negative EBITDA, $100 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The earnings miss and restructuring guidance suggest short‑term downside risk, but the announced focus on critical materials and potential U.S. contracts could be a catalyst later in 2027.

02

Market read

Primary earnings disclosure for a niche metal producer; relevance mainly to sector investors and commodity‑focused traders.

03

What to watch

Potential restart of Venezuelan operations and U.S. government discussions on critical materials may provide upside later.

Relevance 7/10Novelty 7/10Timing: after earnings release

Background

Ferroglobe PLC (GSM) is a global producer of ferroalloys. The Q3 2026 call highlighted energy‑cost pressures, shipment declines, and a restructuring plan.

Market effects

Weakness in ferrosilicon and silicon metal may pressure other European ferroalloy producers.

European ferrosilicon index already down 16% YTD; Ferroglobe's results could deepen regional sell‑off.

Limited to specialty metals sector; unlikely to affect broader markets.

Counterpoint

Cost‑reduction program could improve margins over the next 12‑18 months if energy costs stabilize.

Key entities

  • Marco Levi

    CEO of Ferroglobe, provided guidance on plant closures and critical materials strategy.

  • Beatriz Garcia-Cos Muntanola

    CFO, detailed financial results and cost‑reduction program.

Related articles

$GSMMed

Ferroglobe (GSM) Q3 2026 Earnings Call Transcript

Ferroglobe (GSM) reported a Q3 2026 decline due to high energy costs and regulatory pricing, with adjusted EBITDA at $16M excluding a $18.5M energy impact. The company launched a cost reduction program targeting $100M annual EBITDA improvement, including plant closures and workforce reductions. Progress was noted in critical materials, trade protection, and Venezuela operations. Silicon metal prices rose 10% in the US and 6% in Europe, while volumes declined 6%.

$GSMMed

Ferroglobe Q3 Earnings Call Highlights

Ferroglobe (GSM) plans to cut 20% of its workforce, reducing costs and capital expenditures. Q3 revenue: silicon metal $102M, silicon-based alloys $117M, manganese-based alloys $114M. Adjusted EBITDA: silicon metal -$2M, silicon-based alloys -$2M, manganese-based alloys $11M. Free cash flow $6M. Progress in critical materials initiative. Trade actions support pricing. Venezuela operations pending OFAC license.

$GSMMed

Ferroglobe PLC (GSM): Financial results for Q3 2026

Ferroglobe PLC (GSM) furnished an SEC Form 6-K — earnings release. This Form 6-K consists of the following materials, which appear immediately following this page: ​ ● Press release dated November 3, 2026 announcing results for the quarter ended September 30, 2026 ● Third quarter 2026 earnings call presentation ​ ​ This Form 6-K is being furnish

$GSMMed

Ferroglobe PLC (GSM): Financial results for Q2 2026

Ferroglobe PLC (GSM) furnished an SEC Form 6-K — earnings release. This Form 6-K consists of the following materials, which appear immediately following this page: ​ ● Press release dated August 4, 2026 announcing results for the quarter ended June 30, 2026 ● Second quarter 2026 earnings call presentation ​ ​ This Form 6-K is being furnished for

$CGONHigh

Why is CG Oncology stock surging today?

CG Oncology (CGON) stock rose 19.7% after Q3 2026 results showed a smaller-than-expected loss of $0.64 per share and revenue of $1.60M, both beating estimates. The company announced upcoming clinical trial data and a BLA submission, with a cash position of $984.5M. Analysts have a 'Moderate Buy' rating and $87.50 average price target.

$GMEDHighAI 8/10

Why is Globus Medical stock plunging today?

Globus Medical (GMED) stock fell 12.5% to $71.26, a 52-week low, after Q3 2026 revenue missed estimates at $763.7M, down 0.7% YoY. The company cut full-year revenue guidance to $3.09B. Analysts downgraded the stock, citing weak growth outlook and insider selling. The S&P 500 and Nasdaq rose, but GMED underperformed.